Methods of administering Elagolix
The present disclosure relates to the use of GnRH receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and whe...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
26.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to the use of GnRH receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole. |
---|---|
Bibliography: | Application Number: AU20160317955 |